Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
03 11 2023
Historique:
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Mutational signatures represent a genomic footprint of endogenous and exogenous mutational processes through tumor evolution. However, their functional impact on the proteome remains incompletely understood. We analyzed the protein-coding impact of single-base substitution (SBS) signatures in 12,341 cancer genomes from 18 cancer types. Stop-gain mutations (SGMs) (i.e., nonsense mutations) were strongly enriched in SBS signatures of tobacco smoking, APOBEC cytidine deaminases, and reactive oxygen species. These mutational processes alter specific trinucleotide contexts and thereby substitute serines and glutamic acids with stop codons. SGMs frequently affect cancer hallmark pathways and tumor suppressors such as

Identifiants

pubmed: 37922356
doi: 10.1126/sciadv.adh3083
pmc: PMC10624356
doi:

Substances chimiques

APOBEC3A protein, human EC 3.5.4.5
Cytidine Deaminase EC 3.5.4.5
APOBEC Deaminases EC 3.5.4.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadh3083

Références

Mol Syst Biol. 2013;9:637
pubmed: 23340843
Nature. 2007 Aug 16;448(7155):807-10
pubmed: 17676035
Science. 1997 Mar 21;275(5307):1787-90
pubmed: 9065402
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Oncotarget. 2017 Apr 4;8(14):23831-23840
pubmed: 26625312
Nature. 2019 Nov;575(7781):210-216
pubmed: 31645765
J Pathol. 2022 Feb;256(2):214-222
pubmed: 34816434
Nat Genet. 2019 Dec;51(12):1732-1740
pubmed: 31740835
Science. 2014 Oct 10;346(6206):251-6
pubmed: 25301630
Nature. 2022 Jul;607(7920):799-807
pubmed: 35859169
Nat Commun. 2020 Feb 5;11(1):735
pubmed: 32024846
Science. 1993 Jun 18;260(5115):1816-9
pubmed: 8511591
Redox Biol. 2015 Dec;6:372-385
pubmed: 26339717
Nat Genet. 2013 Sep;45(9):970-6
pubmed: 23852170
Nature. 2021 Jan;589(7842):448-455
pubmed: 33328637
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4858-63
pubmed: 21368204
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Cell Syst. 2018 Mar 28;6(3):271-281.e7
pubmed: 29596782
Nat Rev Cancer. 2004 Mar;4(3):177-83
pubmed: 14993899
Cancer Cell. 2018 Dec 10;34(6):893-905.e8
pubmed: 30537512
Nat Genet. 2023 Feb;55(2):246-254
pubmed: 36702998
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell. 2012 May 25;149(5):979-93
pubmed: 22608084
Sci Transl Med. 2015 Apr 15;7(283):283ra54
pubmed: 25877892
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W193-200
pubmed: 17478515
Exp Mol Med. 2020 Feb;52(2):192-203
pubmed: 32060354
Cell Rep. 2013 Jan 31;3(1):246-59
pubmed: 23318258
DNA Repair (Amst). 2019 Sep;81:102647
pubmed: 31307927
Oncogene. 2002 Oct 21;21(48):7435-51
pubmed: 12379884
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Science. 2016 Nov 4;354(6312):618-622
pubmed: 27811275
Nature. 2003 Jul 3;424(6944):94-8
pubmed: 12808465
Elife. 2021 Jul 08;10:
pubmed: 34236315
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cell. 2017 Jul 27;170(3):534-547.e23
pubmed: 28753428
PLoS Comput Biol. 2022 Aug 10;18(8):e1010393
pubmed: 35947558
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
ACS Chem Biol. 2022 Dec 16;17(12):3379-3388
pubmed: 36475588
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
Cell. 2019 May 2;177(4):821-836.e16
pubmed: 30982602
Nat Genet. 2015 Sep;47(9):1067-72
pubmed: 26258849
Nat Commun. 2016 Sep 12;7:12605
pubmed: 27615322
Cell. 1987 Sep 11;50(6):831-40
pubmed: 3621347
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419
pubmed: 33125078
Mutat Res. 2005 Apr 1;571(1-2):19-31
pubmed: 15748635
Virology. 2015 May;479-480:131-45
pubmed: 25818029
Nature. 1992 Sep 17;359(6392):235-7
pubmed: 1528264
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Cancer Res. 2002 Jul 1;62(13):3659-62
pubmed: 12097271
Sci Signal. 2017 Dec 05;10(508):
pubmed: 29208682
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Nat Commun. 2018 May 10;9(1):1857
pubmed: 29748584
PLoS Genet. 2019 Dec 16;15(12):e1008545
pubmed: 31841499
Chest. 1997 Dec;112(6):1474-9
pubmed: 9404741
Nat Methods. 2019 Jun;16(6):453-454
pubmed: 31133757
Sci Transl Med. 2013 Aug 7;5(197):197ra101
pubmed: 23926199
Nat Genet. 2018 Oct;50(10):1381-1387
pubmed: 30224644
Cancer Cell. 2023 Aug 14;41(8):1427-1449.e12
pubmed: 37478850
Nature. 2023 Aug;620(7973):393-401
pubmed: 37407818
Science. 2019 Jun 28;364(6447):
pubmed: 31249028
PLoS Genet. 2018 Nov 9;14(11):e1007779
pubmed: 30412573

Auteurs

Nina Adler (N)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.

Alexander T Bahcheli (AT)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Kevin C L Cheng (KCL)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Khalid N Al-Zahrani (KN)

Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada.

Mykhaylo Slobodyanyuk (M)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Diogo Pellegrina (D)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.

Daniel Schramek (D)

Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada.

Jüri Reimand (J)

Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH